| Systemic Lupus Erythematosus |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Glucocorticoid |
0 |
0.59 |
| Lupus Nephritis |
0 |
0.55 |
| Lupus |
0 |
0.5 |
| Steroids |
0 |
0.98 |
| Nephritis |
0 |
0.23 |
| Patient Safety |
0 |
0.2 |
| Adverse Effects |
0 |
0.18 |
| Europe |
0 |
0.18 |
| Intravenous |
0 |
0.18 |
| Antineoplastic Drug |
0 |
0.14 |
| Immunization |
0 |
0.14 |
| Monoclonal Antibody |
0 |
0.14 |
| Remission |
0 |
0.14 |
| Antiphospholipid Syndrome |
0 |
0.09 |
| Immunosuppressive Therapy |
0 |
0.09 |
| Prognosis |
0 |
0.09 |
| Proteinuria |
0 |
0.09 |
| Quality of Life |
0 |
0.09 |
| Thromboembolism |
0 |
0.09 |
| Antithrombotics |
0 |
0.08 |